Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Alpha Purchase, 14% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 8 yen
7115 Alpha Purchase Co., Ltd. 【J-GAAP】
Earnings ReportAlpha Purchase Co., Ltd. <7115> [TSE Std] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 increased 3.7% from the previous period to 1.22 billion yen. In the fiscal year ending December 2025, the profit is expected to grow by 14.1% to 1.4 billion yen, marking the eighth consecutive term of record-high profits. This will be the fifth consecutive term of revenue and the eighth consecutive term of profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 35 yen, an increase of 8 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit amounted to 0.4 billion yen, an increase of 2.6% compared to the same period last year. However, the operating profit margin remained almost flat, changing from 2.6% in the same period last year to 2.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 44,383 | 1,042 | 994 | 704 | 84.9 | 15 | Feb 14, 2023 | J-GAAP |
Dec, 2023 | 51,951 | 1,188 | 1,183 | 850 | 89.5 | 22 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 55,952 | 1,242 | 1,227 | 865 | 89.7 | 27 | Feb 14, 2025 | J-GAAP |
YoY | +7.7% | +4.5% | +3.7% | +1.8% | +0.2% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 57,122 | 1,210 | 1,200 | 854 | 88.1 | 27 | Feb 14, 2024 | J-GAAP |
Dec, 2024 Results | 55,952 | 1,242 | 1,227 | 865 | 89.7 | 27 | Feb 14, 2025 | J-GAAP |
Revision Rate | -2.0% | +2.6% | +2.3% | +1.3% | +1.8% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 26,787 | 563 | 548 | 396 | 41.2 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 51,951 | 1,188 | 1,183 | 850 | 89.5 | 22 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 55,952 | 1,242 | 1,227 | 865 | 89.7 | 27 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 61,975 | 1,410 | 1,400 | 979 | 100.9 | 35 | Feb 14, 2025 | J-GAAP |
YoY | +10.8% | +13.5% | +14.1% | +13.2% | +12.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 14,615 | 386 | 390 | 289 | 30.4 | 2.6 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 13,566 | 289 | 273 | 192 | 20.0 | 2.1 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 13,221 | 274 | 275 | 204 | 21.2 | 2.1 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 13,576 | 279 | 279 | 198 | 20.6 | 2.1 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 15,589 | 400 | 400 | 271 | 28.1 | 2.6 | Feb 14, 2025 | J-GAAP |
YoY | +6.7% | +3.6% | +2.6% | -6.2% | -7.6% |
Related Articles
PERSOL HOLDINGS, Apr-Dec (Cumulative 3Q) Net Income Increases by 24%, Oct-Dec Net Income Increases by 16%
WOLVES HAND, First Half Ordinary Profit Decreases by 7%
freee, First Half Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit
NANO MRNA, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
AKIKAWA FOODS&FARMS, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 35%
Billing System, 20% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 3.3 yen
PATH, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Loss Widens
Agent Insurance Group, 92% Increase in Ordinary Profit, Record High for The First Time in Four Years
Atlas Technologies, Returning to Profitability This Year